Joel Schlessinger
Impact in
- Dermatology top 0.5%
- Hidradenitis Suppurativa and Treatments
- Acne and Rosacea Treatments and Effects
- Facial Rejuvenation and Surgery Techniques
- Dermatologic Treatments and Research
- Dermatology and Skin Diseases
- Neurology top 5%
- Botulinum Toxin and Related Neurological Disorders
Papers in
- Dermatology 26
- Dermatologic Treatments and Research 7
- Dermatology and Skin Diseases 7
- Acne and Rosacea Treatments and Effects 6
- Facial Rejuvenation and Surgery Techniques 5
- Neurology 16
- Botulinum Toxin and Related Neurological Disorders 16
- Co-authors
- Philip Werschler (2 shared papers)Joel L. Cohen (8 shared papers)Joel M. Gelfand (3 shared papers)David R. Adams (3 shared papers)Alexa B. Kimball (3 shared papers)Francisco A. Kerdel (3 shared papers)Parvez M Mulani (3 shared papers)Joely Kaufman‐Janette (9 shared papers)
- Journals
- Aesthetic Surgery Journal (9 papers)Dermatologic Surgery (8 papers)Journal of Drugs in Dermatology (4 papers)Journal of the American Academy of Dermatology (3 papers)JAMA Dermatology (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Joel Schlessinger
54 papers receiving 1.6k citations
Joel Schlessinger's Hit Papers
Peers
Comparison fields: 5 of 99
- Dermatology 998
- Neurology 308
- Immunology and Allergy 66
- Surgery 404
- Epidemiology 261
Countries citing papers authored by Joel Schlessinger
This map shows the geographic impact of Joel Schlessinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Schlessinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Schlessinger more than expected).
Fields of papers citing papers by Joel Schlessinger
This network shows the impact of papers produced by Joel Schlessinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Schlessinger. The network helps show where Joel Schlessinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel Schlessinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa Hit paper breakdown → | 2012 | 353 |
| 2 | 2018 | 122 | |
| 3 | Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea. | 2008 | 79 |
| 4 | 2020 | 73 | |
| 5 | 2011 | 68 | |
| 6 | A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. | 2009 | 58 |
| 7 | 2017 | 58 | |
| 8 | 2011 | 56 | |
| 9 | The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. | 2009 | 55 |
| 10 | 2019 | 50 | |
| 11 | 2013 | 48 | |
| 12 | 2012 | 43 | |
| 13 | Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. | 2007 | 43 |
| 14 | A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. | 2007 | 40 |
| 15 | Adalimumab for the treatment of moderate to severe hidradenitis suppurativa:A parallel randomized trial | 2012 | 39 |
| 16 | 2012 | 35 | |
| 17 | 2018 | 33 | |
| 18 | 2020 | 32 | |
| 19 | Perceptions and practices in submental fat treatment: a survey of physicians and patients. | 2013 | 29 |
| 20 | 2006 | 29 |
About Joel Schlessinger
Joel Schlessinger is a scholar working on Dermatology, Neurology, Surgery, Epidemiology and Urology, having authored 61 papers that have together received 1.7k indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (16 papers), Body Contouring and Surgery (9 papers), Dermatologic Treatments and Research (7 papers), Dermatology and Skin Diseases (7 papers), Acne and Rosacea Treatments and Effects (6 papers), Nail Diseases and Treatments (6 papers), Facial Rejuvenation and Surgery Techniques (5 papers) and Body Image and Dysmorphia Studies (4 papers). The work is most often cited by research in Dermatology (998 citations), Neurology (308 citations), Immunology and Allergy (66 citations), Surgery (404 citations) and Epidemiology (261 citations). Joel Schlessinger has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Philip Werschler, Joel L. Cohen, Joel M. Gelfand, David R. Adams, Alexa B. Kimball, Francisco A. Kerdel, Parvez M Mulani, Joely Kaufman‐Janette, Robert Gniadecki and Ulrich Mrowietz. Their work appears in journals such as Aesthetic Surgery Journal, Dermatologic Surgery, Journal of Drugs in Dermatology, Journal of the American Academy of Dermatology and JAMA Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.